Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6282535 | Neuroscience Letters | 2013 | 6 Pages |
Abstract
The peptide amphiphile (PA) with a laminin epitope IKVAV (IKVAV-PA) can be trigged into three-dimensional nanostructures in vivo. Application of IKVAV-PA to the injured spinal cord resulted in significant functional improvement in rodents with remarkable axonal regeneration at the lesion site. Here we showed that injection of IKVAV-PA into the hippocampus of a transgenic (Tg) mice model of Alzheimer's disease (AD) significantly improved cognitive impairment, accompanied by an enhanced neurogenesis in the hippocampus. Further examination demonstrated that IKVAV-PA injections also significantly reduced the levels of soluble Aβ1-40, Aβ1-42, and amyloid-beta (Aβ) plaques in these brains. Our data suggest that IKVAV-PA may serve as a potential therapeutic intervention for the learning and memory losses in AD.
Related Topics
Life Sciences
Neuroscience
Neuroscience (General)
Authors
Hongna Yang, Tingyu Qu, Hui Yang, Lifei Wei, Zhaohong Xie, Ping Wang, Jianzhong Bi,